[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:burkitt-leukemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Burkitt Leukemia",3,[7,14,21],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT05794880","MCW Alpha\u002FBeta T-Cell and B-Cell Depletion With Targeted ATG Dosing",[],"RECRUITING","2026-08-26T02:18:43.501109Z","2026-05-05T02:43:29.363482Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT03136146","Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma\u002FLeukemia, or Double-Hit Lymphoma\u002FLeukemia",[18],"Phase 2","2026-08-26T02:18:35.425468Z","2026-05-05T02:43:28.565200Z",{"nct_id":22,"title":23,"phases":24,"status":11,"updated_at":25,"content_modified":26},"NCT03779854","Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant",[18],"2026-08-26T02:16:18.872924Z","2026-05-05T02:43:27.279311Z",[],[]]